This research demonstrates a novel photocatalytic method for synthesizing tetrahydroquinolines, indicating a sustainable solution for chemical production.
Tetrahydroquinolines (THQs) are essential scaffolds in natural products and pharmaceutical agents, and feasible synthetic assembly strategies for them remain highly desirable. Photocatalysis presents an ecofriendly and atom-utilizing pathway for obtaining THQs; however, the development of high-performance photocatalysts for this transformation is still a formidable task. Here, we introduce Cu@NU-1000, a defect-engineered photocatalyst fabricated by embedding copper species into the secondary building units (SBUs) of Zr-based metal-organic framework (MOF) NU-1000. Introducing copper species alters the electronic structure of NU-1000, thereby facilitating charge redistribution and enhancing electron-hole separation. In addition, the inherent structural characteristics of MOFs, such as high porosity and large specific surface area, further promote selective substrate adsorption and activation. The Cu/Zr centers and pyrene linkers act synergistically as dual active sites, significantly enhancing the catalytic activity of Cu@NU-1000. The resulting photocatalytic system exhibits a broad substrate scope and remarkable efficiency, enabling the synthesis of THQs in yields as high as 94% with a significantly reduced catalyst loading. Furthermore, this catalytic system achieves remarkable recyclability over at least five cycles. This research not only presents a strong approach to enhance the photocatalytic efficiency of the materials but also creates a versatile platform for the mild and sustainable photoproduction of THQs derivatives.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: